<DOC>
	<DOCNO>NCT00556062</DOCNO>
	<brief_summary>To evaluate safety immunogenicity three consecutive lot seasonal split influenza vaccine Anflu adult , randomize , double-blind control clinical trial conduct 560 subject Tianjin City China .</brief_summary>
	<brief_title>Phase IV Clinical Trial Influenza Split Vaccine Anflu</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy adult age 1860 year old Be able show legal identity card sake recruitment Without vaccination history seasonal split influenza vaccine recent 3 year Not participate clinical trial study Not receive immunosuppressive agent one month prior study Be able understand sign inform consent . Womanï¼š Who breastfeed plan become pregnant study Any history allergic reaction ; allergic component vaccine , egg ovalbumin Any history severe adverse reaction vaccine , anaphylaxis , hive , respiratory difficulty , angioedema , abdominal pain Autoimmune disease immunodeficiency Acute episode chronic disease condition , include chronic hepatitis , hypertension , diabetes mellitus cardiovascular disease GuillainBarre Syndrome Women subject positive urinary pregnancy test Any history immunosuppressive medication cytotoxic medication inhale corticosteroid within past six month ( exception corticosteroid nasal spray allergic rhinitis topical corticosteroid acute uncomplicated dermatitis ) Axillary temperature &gt; 37.0 centigrade time dose Psychiatric condition precludes compliance protocol ; past present psychosis ; past present bipolar disorder require therapy well control medication past two year ; disorder require lithium ; suicidal ideation occur within five year prior enrollment Any medical , psychiatric , social condition , occupational reason responsibility , judgment investigator , contraindication protocol participation impair volunteer 's ability give inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>